AZETIDINES AS MEK INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

Spoj formule I: ili pojedinačni stereoizomer ili smjesa stereoizomera, ili po izboru njegova farmaceutski prihvatljiva sol ili solvat, naznačen time što su A, X, R1, R2, R3, R4, R5, R6 i R7 kako je definirano za grupu A, grupu B, grupu C ili grupu D: Grupa A: A je arilen po izboru supstituiran s jed...

Full description

Saved in:
Bibliographic Details
Main Authors JOERG BUSSENIUS, JEAN-CLAIRE LIMUN MANALO, CHARLES M. BLAZEY, NEEL KUMAR ANAND, JEFFRY KIMO CURTIS, SIMONA COSTANZO, ELENA KOLTUN, OWEN JOSEPH BOWLES, TSZE H. TSANG, ANGIE INYOUNG KIM, LARISA DUBENKO, CSABA J. PETO, ABIGAIL R. KENNEDY, NAING AAY, STEVEN CHARLES DEFINA, ANAGHA ABHIJIT JOSHI, KENNETH D. RICE
Format Patent
LanguageCroatian
English
Published 31.08.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Spoj formule I: ili pojedinačni stereoizomer ili smjesa stereoizomera, ili po izboru njegova farmaceutski prihvatljiva sol ili solvat, naznačen time što su A, X, R1, R2, R3, R4, R5, R6 i R7 kako je definirano za grupu A, grupu B, grupu C ili grupu D: Grupa A: A je arilen po izboru supstituiran s jednom, dvije, tri ili četiri skupine izabrane između R10, R12, R14 iR16 gdje su R1O, R12, R14 i R16 nezavisno jedan od drugog vodik, alkil, alkenil, alkinil, halogen, halogenalkoksi, hidroksi, alkoksi, amino, alkilamino, dialkilamino, halogenalkil, -NHS(O)2R8, -CN, -C(O)R8, -C(O)OR8, -C(O)NR8R8' i -NR8C(O)R8'; X je alkil, halogen, halogenalkil ili halogenalkoksi; R1, R2, R3, R4, R5 i R6 su nezavisno vodik, halogen, nitro, NR8R8', -OR8, -NHS(O)2R8, -CN, -S(O)mR8, Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.
AbstractList Spoj formule I: ili pojedinačni stereoizomer ili smjesa stereoizomera, ili po izboru njegova farmaceutski prihvatljiva sol ili solvat, naznačen time što su A, X, R1, R2, R3, R4, R5, R6 i R7 kako je definirano za grupu A, grupu B, grupu C ili grupu D: Grupa A: A je arilen po izboru supstituiran s jednom, dvije, tri ili četiri skupine izabrane između R10, R12, R14 iR16 gdje su R1O, R12, R14 i R16 nezavisno jedan od drugog vodik, alkil, alkenil, alkinil, halogen, halogenalkoksi, hidroksi, alkoksi, amino, alkilamino, dialkilamino, halogenalkil, -NHS(O)2R8, -CN, -C(O)R8, -C(O)OR8, -C(O)NR8R8' i -NR8C(O)R8'; X je alkil, halogen, halogenalkil ili halogenalkoksi; R1, R2, R3, R4, R5 i R6 su nezavisno vodik, halogen, nitro, NR8R8', -OR8, -NHS(O)2R8, -CN, -S(O)mR8, Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.
Author ANAGHA ABHIJIT JOSHI
CSABA J. PETO
CHARLES M. BLAZEY
KENNETH D. RICE
ANGIE INYOUNG KIM
ELENA KOLTUN
JEAN-CLAIRE LIMUN MANALO
STEVEN CHARLES DEFINA
NEEL KUMAR ANAND
JOERG BUSSENIUS
OWEN JOSEPH BOWLES
ABIGAIL R. KENNEDY
JEFFRY KIMO CURTIS
NAING AAY
TSZE H. TSANG
SIMONA COSTANZO
LARISA DUBENKO
Author_xml – fullname: JOERG BUSSENIUS
– fullname: JEAN-CLAIRE LIMUN MANALO
– fullname: CHARLES M. BLAZEY
– fullname: NEEL KUMAR ANAND
– fullname: JEFFRY KIMO CURTIS
– fullname: SIMONA COSTANZO
– fullname: ELENA KOLTUN
– fullname: OWEN JOSEPH BOWLES
– fullname: TSZE H. TSANG
– fullname: ANGIE INYOUNG KIM
– fullname: LARISA DUBENKO
– fullname: CSABA J. PETO
– fullname: ABIGAIL R. KENNEDY
– fullname: NAING AAY
– fullname: STEVEN CHARLES DEFINA
– fullname: ANAGHA ABHIJIT JOSHI
– fullname: KENNETH D. RICE
BookMark eNqNyr0KwjAQAOAMOvj3DgfOQqMddIz2Qg5tU3KHg0spck6SFur74-IDOH3LtzSzPGRdmOAeKFRRgwyOocYrUBPoTBITg48JJCBIQic1NgLRQ5vijTwmJ3RHqIjRMfLazF_9e9LNz5XZepRL2Ok4dDqN_VOzfrqQ2n1hbVGejiL28N_6AvO7MB8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate AZETIDINI KAO INHIBITORI MEK ZA LIJEČENJE PROLIFERATIVNIH BOLESTI
ExternalDocumentID HRP20110498TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_HRP20110498TT13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:57:35 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Croatian
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HRP20110498TT13
Notes Application Number: HR2011P000498T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110831&DB=EPODOC&CC=HR&NR=P20110498T1
ParticipantIDs epo_espacenet_HRP20110498TT1
PublicationCentury 2000
PublicationDate 20110831
PublicationDateYYYYMMDD 2011-08-31
PublicationDate_xml – month: 08
  year: 2011
  text: 20110831
  day: 31
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies EXELIXIS
RelatedCompanies_xml – name: EXELIXIS
Score 2.8187828
Snippet Spoj formule I: ili pojedinačni stereoizomer ili smjesa stereoizomera, ili po izboru njegova farmaceutski prihvatljiva sol ili solvat, naznačen time što su A,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title AZETIDINES AS MEK INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110831&DB=EPODOC&locale=&CC=HR&NR=P20110498T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0SkDpW5Gt7do9FOnalFTdWro4hi9jbVoQoRuu4r_vJWzOp72FHBzHwX0m9zuAB-HY5ULkjm6IgaOb-cLUF2XZ1y2zKIVRYpKg4ItH4z57M59n1qwBn9tZGIUT-qPAEdGicrT3Wvnr1a6JFai_levH7AOvlk8hdwNNbNt9cnGWFgxdmsRB7Gu-77JUG6duoojmwOFYKh1gHm1Lc6DToRxLWf2PKeEpHCbIrqrPoFFULTj2t6vXWnA02rx443FjfOtzYN475VEg12QQb0JG9IVEYxYNIx6nE4LVHOGMEp5Sj0uEfhKHJEnj1yikshE1pSSIJtRD_3kB9yHlPtNRpPmfAuYs3YnPu8YlNKtlVVwB6Yusm-US9Q2zgswoMPmwesKyJQiMXVq9NnT2cbreT76Bk10HtQPN-uu7uMUQXGd3SnW_iJ2EDw
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1IDStyJb27V7KNK1KYlbP-jiGL6M9QtE6Iar-O-bhM35tLeQg-M4uM_kfgfwlFtmucwzS9XyoaXq2VJXl2U5UA29KHOt5EmChC8OwgF501_nxrwBn7tZGIkT-iPBEblFZdzea-mv1_smlif_Vm6e0w9-tXrxme0p-a7dJxZnKd7IxnHkRa7iujZJlDCxY0nUhxbjpdIRz7FNYQ54NhJjKev_McU_g-OYs6vqc2gUVRta7m71WhtOgu2LNz9ujW9zAcR5x4x6Yk0GcqYowGNEQ0JHlEXJFPFqDjGCEUuwwwRCP4p8FCfRhPpYNKJmGHl0ih3uPy_h0cfMJSoXafGngAVJ9uKznnYFzWpVFdeABnnaSzOB-sazglQrePJh9HPDFCAwZmn0O9A9xOnmMPkBWoQFk8WEhuNbON13U7vQrL--izsejuv0XqrxF-ZMhwI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=AZETIDINES+AS+MEK+INHIBITORS+FOR+THE+TREATMENT+OF+PROLIFERATIVE+DISEASES&rft.inventor=JOERG+BUSSENIUS&rft.inventor=JEAN-CLAIRE+LIMUN+MANALO&rft.inventor=CHARLES+M.+BLAZEY&rft.inventor=NEEL+KUMAR+ANAND&rft.inventor=JEFFRY+KIMO+CURTIS&rft.inventor=SIMONA+COSTANZO&rft.inventor=ELENA+KOLTUN&rft.inventor=OWEN+JOSEPH+BOWLES&rft.inventor=TSZE+H.+TSANG&rft.inventor=ANGIE+INYOUNG+KIM&rft.inventor=LARISA+DUBENKO&rft.inventor=CSABA+J.+PETO&rft.inventor=ABIGAIL+R.+KENNEDY&rft.inventor=NAING+AAY&rft.inventor=STEVEN+CHARLES+DEFINA&rft.inventor=ANAGHA+ABHIJIT+JOSHI&rft.inventor=KENNETH+D.+RICE&rft.date=2011-08-31&rft.externalDBID=T1&rft.externalDocID=HRP20110498TT1